methyldopa has been researched along with Paranoia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, M; Hirai, K; Ohara, M | 1 |
| Gershon, S; Wallach, MB | 1 |
| Galanter, M; Green, R; Kaplan, J; Vaughan, T; Wyatt, RJ | 1 |
1 trial(s) available for methyldopa and Paranoia
| Article | Year |
|---|---|
Behavioral changes of chronic schizophrenic patients given L-5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Administration, Oral; Adult; Brain; Carboxy-Lyases; Clinical Trials as Topic; Humans; Hydrazines; Hydroxyindoleacetic Acid; Male; Methyldopa; Paranoid Disorders; Placebos; Schizophrenia; Serotonin | 1972 |
2 other study(ies) available for methyldopa and Paranoia
| Article | Year |
|---|---|
Paranoid-hallucinatory state induced in a depressive patient by methyldopa: a case report.
Topics: Adjustment Disorders; Aged; Blood Pressure; Female; Hallucinations; Humans; Methyldopa; Paranoid Disorders | 1978 |
A neuropsychopharmacological comparison of d-amphetamine, L-dopa and cocaine.
Topics: Animals; Behavior, Animal; Cats; Cocaine; Cortical Synchronization; Dextroamphetamine; Dihydroxyphenylalanine; Electroencephalography; Female; Hair; Humans; Hydrazines; Male; Methyldopa; Paranoid Disorders; Parkinson Disease; Phenethylamines; Reticular Formation; Salivation; Sleep, REM; Stereoisomerism | 1971 |